Guizhou Yibai Pharmaceutical Co Ltd (600594) - Total Assets
Based on the latest financial reports, Guizhou Yibai Pharmaceutical Co Ltd (600594) holds total assets worth CN¥3.40 Billion CNY (≈ $497.27 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Guizhou Yibai Pharmaceutical Co Ltd - Total Assets Trend (2001–2025)
This chart illustrates how Guizhou Yibai Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see 600594 market cap for the company's overall valuation and market capitalisation.
Guizhou Yibai Pharmaceutical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Guizhou Yibai Pharmaceutical Co Ltd's total assets of CN¥3.40 Billion consist of 42.1% current assets and 57.9% non-current assets. Review how much debt does Guizhou Yibai Pharmaceutical Co Ltd carry to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 13.0% |
| Accounts Receivable | CN¥167.34 Million | 4.9% |
| Inventory | CN¥546.90 Million | 15.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥312.29 Million | 9.1% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2001–2025)
This chart illustrates how Guizhou Yibai Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Guizhou Yibai Pharmaceutical Co Ltd stock price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Guizhou Yibai Pharmaceutical Co Ltd's current assets represent 42.1% of total assets in 2025, a decrease from 82.1% in 2001.
- Cash Position: Cash and equivalents constituted 13.0% of total assets in 2025, down from 16.8% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 1.0% in 2001.
- Asset Diversification: The largest asset category is inventory at 15.9% of total assets.
Guizhou Yibai Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Guizhou Yibai Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Beijing Tongrentang Co Ltd
SHG:600085
|
China | CN¥31.82 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Neuland Laboratories Limited
NSE:NEULANDLAB
|
India | Rs29.30 Billion |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062
|
China | CN¥17.01 Billion |
Guizhou Yibai Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.70 | 1.84 | 1.74 |
| Quick Ratio | 1.06 | 1.20 | 1.33 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥595.13 Million | CN¥770.94 Million | CN¥940.39 Million |
Guizhou Yibai Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Guizhou Yibai Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.39 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | -16.0% |
| Total Assets | CN¥3.44 Billion |
| Market Capitalization | $403.28 Million USD |
Valuation Analysis
Below Book Valuation: The market values Guizhou Yibai Pharmaceutical Co Ltd's assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Guizhou Yibai Pharmaceutical Co Ltd's assets decreased by 16.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Guizhou Yibai Pharmaceutical Co Ltd (2001–2025)
The table below shows the annual total assets of Guizhou Yibai Pharmaceutical Co Ltd from 2001 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥3.44 Billion ≈ $503.65 Million |
-16.05% |
| 2024-12-31 | CN¥4.10 Billion ≈ $599.92 Million |
-10.82% |
| 2023-12-31 | CN¥4.60 Billion ≈ $672.72 Million |
-5.52% |
| 2022-12-31 | CN¥4.87 Billion ≈ $712.02 Million |
-3.99% |
| 2021-12-31 | CN¥5.07 Billion ≈ $741.61 Million |
-3.03% |
| 2020-12-31 | CN¥5.23 Billion ≈ $764.78 Million |
-6.97% |
| 2019-12-31 | CN¥5.62 Billion ≈ $822.09 Million |
-13.24% |
| 2018-12-31 | CN¥6.48 Billion ≈ $947.58 Million |
-9.99% |
| 2017-12-31 | CN¥7.19 Billion ≈ $1.05 Billion |
+9.19% |
| 2016-12-31 | CN¥6.59 Billion ≈ $964.17 Million |
+17.92% |
| 2015-12-31 | CN¥5.59 Billion ≈ $817.64 Million |
+1.67% |
| 2014-12-31 | CN¥5.50 Billion ≈ $804.19 Million |
+71.69% |
| 2013-12-31 | CN¥3.20 Billion ≈ $468.39 Million |
+40.58% |
| 2012-12-31 | CN¥2.28 Billion ≈ $333.18 Million |
+26.23% |
| 2011-12-31 | CN¥1.80 Billion ≈ $263.94 Million |
+15.26% |
| 2010-12-31 | CN¥1.56 Billion ≈ $228.99 Million |
+22.04% |
| 2009-12-31 | CN¥1.28 Billion ≈ $187.63 Million |
+5.20% |
| 2008-12-31 | CN¥1.22 Billion ≈ $178.35 Million |
+6.89% |
| 2007-12-31 | CN¥1.14 Billion ≈ $166.86 Million |
+15.42% |
| 2006-12-31 | CN¥987.97 Million ≈ $144.57 Million |
-17.67% |
| 2005-12-31 | CN¥1.20 Billion ≈ $175.60 Million |
+38.29% |
| 2004-12-31 | CN¥867.80 Million ≈ $126.99 Million |
+90.66% |
| 2003-12-31 | CN¥455.14 Million ≈ $66.60 Million |
+50.18% |
| 2002-12-31 | CN¥303.07 Million ≈ $44.35 Million |
+39.15% |
| 2001-12-31 | CN¥217.81 Million ≈ $31.87 Million |
-- |
About Guizhou Yibai Pharmaceutical Co Ltd
Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells novel pharmaceutical products in China. The company offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, lyophilized powder injections, dripping pills, and oral solutions in the areas of tumor system, cerebrovascular and cardiovascular, respirato… Read more